Ranibizumab Intraocular and Supress A
Determining the interaction of Ranibizumab Intraocular and Supress A and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: dexbrompheniramine / dextromethorphan / phenylephrine
Brand name: Alahist DM, Bionatuss, G-P-Tuss DXP, Supress A, Alahist CF, Panatuss DXP, Supress A Pediatric, Tussall, Tussall-ER, Dexall, Y-Cof DM, Panatuss Pediatric DXP
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab Intraocular-Supress A Pediatric
- Ranibizumab Intraocular-Supress-PE
- Ranibizumab Intraocular-Sure Result DSS Premium Pak
- Ranibizumab Intraocular-Surfak
- Ranibizumab Intraocular-Surmontil
- Ranibizumab Intraocular-Sustiva
- Supress A-Ranibizumab ophthalmic
- Supress A-Ranitidine
- Supress A-Ranitidine Capsule
- Supress A-Ranitidine Hydrochloride
- Supress A-Ranitidine Injection
- Supress A-Ranitidine Suspension